The FDA has asked all manufacturers of a particular heartburn medicine known as ranitidine, sold under several brands including Zantac, to withdraw their drugs because “unacceptable levels” of a possible carcinogen may develop in the pills over time.
FDA asks manufacturers to recall heartburn drugs over traces of a possible carcinogen.. #pharma #heartburn #Zantac #carcinogen #cancer #NDMA